Generate Biomedicines, Inc. GENB
$13.19
▼ -4.25% 24H
About
Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. Its primary purpose is to program biology to generate optimal therapeutics for significant impact on human health, leveraging the Generate Platform, a therapeutic are…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees312
TickerGENB
Statistics
Market Cap$1.69B
Revenue (TTM)$30.9M
Net Income—
Net Margin—
EPS—
P/E-5.91
P/S54.71
P/B3.22
EV/EBITDA-5.07
ROE40.0%
Dividend Yield—
Price$13.19
Data: Twelve Data · Revenue = mcap / P/S